96 related articles for article (PubMed ID: 851208)
1. Chemical lonization mass spectrometric measurement of alpha-methyldopa and s-dopa metabolites in rat brain regions.
Freed CR; Weinkam RJ; Melmon KL; Castagnoli N
Anal Biochem; 1977 Apr; 78(2):319-32. PubMed ID: 851208
[No Abstract] [Full Text] [Related]
2. Regional distribution of catecholamines in rat brain after L-3-O-methyldopa and L-dopa.
Bartholini G; Lloyd KG; Pletscher A
Life Sci; 1974 Jan; 14(2):323-8. PubMed ID: 4813592
[No Abstract] [Full Text] [Related]
3. Effect of L-DOPA on S-adenosylmethionine levels and norepinephrine metabolism in rat brain.
Wurtman RJ
Adv Biochem Psychopharmacol; 1972; 6():241-6. PubMed ID: 5055596
[No Abstract] [Full Text] [Related]
4. Catecholamine metabolism in the brains of ageing male mice.
Finch CE
Brain Res; 1973 Mar; 52():261-76. PubMed ID: 4700706
[No Abstract] [Full Text] [Related]
5. Brain tissue and plasma assay of L-DOPA and alpha-methyldopa metabolites by high performance liquid chromatography with electrochemical detection.
Freed CR; Asmus PA
J Neurochem; 1979 Jan; 32(1):163-8. PubMed ID: 759567
[No Abstract] [Full Text] [Related]
6. Changes in brain catecholamine levels following DL-dopa are not potentiated by deuterium substitution.
Dewar KM; Dyck LE; Durden DA; Boulton AA
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):675-80. PubMed ID: 3937178
[TBL] [Abstract][Full Text] [Related]
7. 3-O-methyldopa uptake and inhibition of L-dopa at the blood-brain barrier.
Wade LA; Katzman R
Life Sci; 1975 Jul; 17(1):131-6. PubMed ID: 1143006
[No Abstract] [Full Text] [Related]
8. Stereochemical course in vivo of alpha-methyldopa decarboxylation in rat brains.
Ames MM; Melmon KL; Castagnoli N
Biochem Pharmacol; 1977 Oct; 26(19):1757-62. PubMed ID: 334182
[No Abstract] [Full Text] [Related]
9. Effects of methyldopa metabolites on amine transmitters and adrenergic receptors in rat brain.
Louis WJ; Conway E; Summers R; Beart P; Jarrott B
Hypertension; 1984; 6(5 Pt 2):II40-4. PubMed ID: 6094348
[TBL] [Abstract][Full Text] [Related]
10. Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain.
Romero JA; Chalmers JP; Cottman K; Lytle LD; Wurtman RJ
J Pharmacol Exp Ther; 1972 Feb; 180(2):277-85. PubMed ID: 5010674
[No Abstract] [Full Text] [Related]
11. Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats.
Schoenfeld RI; Uretsky NJ
J Pharmacol Exp Ther; 1973 Sep; 186(3):616-24. PubMed ID: 4728340
[No Abstract] [Full Text] [Related]
12. Absorption, metabolism and distribution of (14C)-O-methyldopa and (14C)-L-dopa after oral administration to rats.
Rivera-Calimlim L
Br J Pharmacol; 1974 Feb; 50(2):259-63. PubMed ID: 4425764
[TBL] [Abstract][Full Text] [Related]
13. Drugs affecting monoamines in the basal ganglia.
Bartholini G; Pletscher A
Adv Biochem Psychopharmacol; 1972; 6():135-48. PubMed ID: 4560163
[No Abstract] [Full Text] [Related]
14. L-dopa-induced accumulation of 3-O-metyldopa in brain and heart.
Kuruma I; Bartholini G; Pletscher A
Eur J Pharmacol; 1970 May; 10(2):189-92. PubMed ID: 5446374
[No Abstract] [Full Text] [Related]
15. L-dopa in Parkinsonism. A possible mechanism of action.
Ng LK; Chase TN; Colburn RW; Kopin IJ
Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
[No Abstract] [Full Text] [Related]
16. Synthetic amino acids and the nature of L-DOPA transport at the blood-brain barrier.
Wade LA; Katzman R
J Neurochem; 1975 Dec; 25(6):837-42. PubMed ID: 1206400
[No Abstract] [Full Text] [Related]
17. The effect of L-DOPA on brain polysomes and protein synthesis: probable mediation by intracellular dopamine.
Weiss BF; Roel LE; Munro HN; Wurtman RJ
Adv Neurol; 1974; 5():87-99. PubMed ID: 4155238
[No Abstract] [Full Text] [Related]
18. Antihypertensive metabolites of alpha-methyldopa.
Robertson D; Tung CS; Goldberg MR; Hollister AS; Gerkens JF; Oates JA
Hypertension; 1984; 6(5 Pt 2):II45-50. PubMed ID: 6094349
[TBL] [Abstract][Full Text] [Related]
19. Studies on rheomelanins. I. The formation of rheomelanins in human blood plasma from catecholamines, from L-dopa and from some of their derivatives.
Hegedus ZL; Altschule MD
Arch Int Physiol Biochim; 1970 Aug; 78(3):443-59. PubMed ID: 4097994
[No Abstract] [Full Text] [Related]
20. Effects of chronically administered L-dopa in normal and lesioned cats.
Langelier P; Roberge AG; Boucher R; Poirier LJ
J Pharmacol Exp Ther; 1973 Oct; 187(1):15-26. PubMed ID: 4746324
[No Abstract] [Full Text] [Related]
[Next] [New Search]
